OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	209.64B +11.1%
Revenue (ttm)	14.37B -0.6%
Net Income	-738.03M
EPS	-6.44
Shares Out	114.64M
PE Ratio	n/a
Forward PE	44.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,162
Open	1,815.10
Previous Close	1,828.60
Day's Range	1,804.10 - 1,828.70
52-Week Range	1,057.00 - 2,248.00
Beta	n/a
Analysts	Buy
Price Target	2,036.75 (+12.62%)
Earnings Date	May 13, 2026

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,412
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In fiscal year 2026, NSE:ONESOURCE's revenue was 14.37 billion, a decrease of -0.57% compared to the previous year's 14.45 billion. Losses were -738.03 million, 310.7% more than in 2025.